Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

351 Press Releases
DateTitleCompany
28 Apr 17 Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA Sanofi,
Published by
GlobeNewswire
25 Apr 17 New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio® (teriflunomide) on Cortical Gray Matter Atrophy Sanofi Genzyme,
Published by
Business Wire
25 Apr 17 Sanofi Receives FDA Approval of Thymoglobulin® for the Prevention of Acute Kidney Transplant Rejection Sanofi ,
Published by
PharmiWeb.com
24 Apr 17 Sanofi and Regeneron Receive CHMP Positive Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Sanofi,
Published by
GlobeNewswire
14 Apr 17 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the... Sanofi,
Published by
GlobeNewswire
05 Apr 17 Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee Sanofi,
Published by
GlobeNewswire
03 Apr 17 Sanofi Launches First-Ever ACT® Kids Toothpaste in the U.S. Sanofi,
Published by
PR Newswire
02 Apr 17 Switching to Sanofi's Toujeo® Showed Significant Reductions in Blood Sugar and Significantly Lower Incidence of Hypoglycemia in a Real-World Observational Study Sanofi,
Published by
PR Newswire
30 Mar 17 Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis Sanofi ,
Published by
PharmiWeb.com
23 Mar 17 Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help Improve Patient Outcomes through Peer-to-Peer Education Sanofi,
Published by
PharmiWeb.com
17 Mar 17 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the... Sanofi,
Published by
GlobeNewswire
14 Mar 17 UK Patients Granted Early Access to Sanofi’s Innovative Dermatology Treatment Dupilumab by MHRA Sanofi,
Published by
PharmiWeb.com
06 Mar 17 Sanofi Pasteur and MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV Sanofi Pasteur ,
Published by
PharmiWeb.com
06 Mar 17 Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charlès as New Independent Directors Sanofi,
Published by
PharmiWeb.com
03 Mar 17 Sanofi: Filing of the 2016 U.S. Form 20-F and French "Document de Référence" containing the Annual Financial Report Sanofi,
Published by
GlobeNewswire
03 Mar 17 Sanofi Pasteur and MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV Sanofi,
Published by
GlobeNewswire
02 Mar 17 Sanofi : Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charlès as New Independent Directors Sanofi,
Published by
GlobeNewswire
28 Feb 17 Sanofi Genzyme Recognizes Rare Disease Day 2017 with Programs of Events around the World Sanofi Genzyme,
Published by
Business Wire
04 Jan 17 Sanofi Announces Soliqua(TM) 100/33 Now Available in the U.S. Sanofi ,
Published by
PharmiWeb.com
14 Feb 17 Sanofi Initiates Phase 2 Clinical Trial to Evaluate Therapy for Genetic Form of Parkinson’s Disease Sanofi Genzyme,
Published by
Business Wire
30 Jan 17 Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs Sanofi,
Published by
GlobeNewswire
27 Feb 17 Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility Sanofi,
Published by
GlobeNewswire
17 Jan 17 Sanofi: SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
27 Feb 17 Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses Sanofi ,
Published by
PharmiWeb.com
06 Jan 17 Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection Sanofi,
Published by
GlobeNewswire
01 Feb 17 Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States Sanofi,
Published by
GlobeNewswire
23 Jan 17 Sanofi : Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
31 Jan 17 Sanofi Pasteur Announces the Availability of Quadracel™ DTaP-IPV Vaccine for Children 4 Through 6 Years of Age in the U.S. Sanofi Pasteur ,
Published by
PharmiWeb.com
08 Feb 17 Sanofi CEO Interview - FY 2016 Results (video) Sanofi,
Published by
PR Newswire
09 Feb 17 Sanofi: Appeals Court Grants Stay of Permanent Injunction for Praluent® (alirocumab) During Appeals Process Sanofi,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.